Future Directions of Maintenance Therapy in ANCA-associated Vasculitis

Curr Med Chem. 2023;30(27):3052-3059. doi: 10.2174/0929867330666230220101730.
No abstract available

Keywords: ANCA-vasculitis; B-cells; CAR T-cells; avacopan; complement; maintenance treatment; recurrence; rituximab.

MeSH terms

  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis* / drug therapy
  • Humans
  • Immunosuppressive Agents*

Substances

  • Immunosuppressive Agents